Device Trial Radar · NCT06941610
An Evaluation of the Erchonia Laser As a Non-Invasive Treatment to Improve the Appearance of Skin Laxity
Last checked: Nov 20, 2026Latest source record: Jun 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
9
Actual
Start
May 30, 2025
Primary completion
Feb 12, 2026
Study completion Feb 12, 2026
Sponsor
- Lead sponsor
- Erchonia CorporationNot on our public-company list
- Sponsor type
- Industry
- First posted
- Apr 24, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 22 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this clinical study is to determine the effectiveness of the Erchonia® GVS in improving the appearance of skin laxity on the abdominal region.
Conditions
- Skin Laxity
Interventions
Erchonia GVS LaserDevice
405nm violet and 520nm green laser light therapy.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of Accurately Identified Subject Pre- and Post-treatment Photographs by at Least Two of the Three Blinded Independent Evaluators.Time frame: 12 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Cesar A. Lara M.D. Weight Loss & Wellness
Dunedin, Florida
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.